Cutaneous Neurofibroma

• CLINICAL_TRIALS research · 2026-04-22
  Clinical Trial Update: Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs) [Phase 1]

  A Phase 1 study at Massachusetts General Hospital is evaluating repeat monthly injections of sodium deoxycholate for cutaneous neurofibromas…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). [Phase 1, Phase 2]

  Clinical trial update indicating recruitment for Mirdametinib monotherapy in adults with Neurofibromatosis type 1 and cutaneous neurofibroma…

• CLINICAL_TRIALS trial_result · 2026-02-17
  Clinical Trial Update: NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) [Phase 2]

  Phase 2 trial of NFX-179 topical gel for adults with Neurofibromatosis Type 1 and cutaneous neurofibromas has completed, and results have be…

• CLINICAL_TRIALS trial_result · 2025-07-24
  Clinical Trial Update: Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

  A completed clinical trial update exploring the mechanisms behind cutaneous neurofibroma formation in neurofibromatosis type 1 using a trans…

• CLINICAL_TRIALS trial_result · 2024-10-16
  Clinical Trial Update: HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy [NA]

  This completed clinical trial evaluated high-intensity focused ultrasound (HIFU) for treating cutaneous neurofibromas in Neurofibromatosis T…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-05-06
  Clinical Trial Update: DPCP to Treat Cutaneous Neurofibromas Associated With NF1 [Phase 1]

  Phase 1 trial evaluating diphenylcyclopropenone (DPCP) for treating cutaneous neurofibromas in Neurofibromatosis Type 1 has completed.

• CLINICAL_TRIALS trial_result · 2023-12-05
  Clinical Trial Update: Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma [Phase 2]

  Phase 2 trial update for selumetinib in Neurofibromatosis Type 1 with cutaneous neurofibromas; study completed with results posted in late 2…

• CLINICAL_TRIALS trial_result · 2022-08-09
  Clinical Trial Update: NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) [Phase 2]

  A Phase 2 clinical trial of NFX-179 topical gel for adults with Neurofibromatosis type 1 and cutaneous neurofibromas has completed with resu…